Eballena, Zaye Seff .

HRN: 23-47-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
CEFUROXIME 750MG (VIAL)
09/06/2024
09/12/2024
IVTT
320mg
Q8h
Pcap C
Waiting Final Action 
09/07/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/07/2024
09/13/2024
IVTT
140mg
Q24h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: